Celldemic Seqirus Pty Ltd
Product name
Celldemic
Sponsor
Accepted date
May-2024
Active ingredients
Influenza virus haemagglutinin
Proposed indication
For active immunisation in persons from 6 months of age, to prevent influenza disease caused by the influenza A virus.
Application type
A (new medicine)
Publication date
May-2024